REFRACTORY ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA

Clinical trials for REFRACTORY ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo trial offers hope for Tough-to-Treat uterine cancer

Disease control Ongoing

This study is testing whether adding a drug called ribociclib to a two-drug combination (everolimus and letrozole) works better for women with advanced or returning endometrial cancer. The trial will enroll 90 participants to see if the three-drug combo helps control the cancer l…

Matched conditions: REFRACTORY ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

REFRACTORY ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA

Get alerted when new REFRACTORY ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA trials appear

New drug combo trial offers hope for Tough-to-Treat uterine cancer